Vivus Obesity Drug Works?

12/15/2008 (1 d 19 h ago)

Photo courtesy of iStockphoto , Image# 306495
Vivus Inc. - the maker of the obesity drug Qnexa - has reported that obese patients treated with the highest dose of its experimental drug Qnexa on average lost 9.2 percent of their weight.

Such were the findings from the first of three late-stage trials involving Qnexa - a mixture of phentermine (half of the recalled fen-phen diet pill) and the epilepsy drug Topamax (topiramate).

Vivus said the 28-week, 756-patient study met its main goal of superior weight loss with two different doses of Qnexa, compared with the drug's individual components and a placebo pill. Patients in the placebo group on average lost 1.7 percent of their weight, while patients on "mid-dose" Qnexa lost 8.5 percent.

Hmmm...I don't 9.2 percent is a big loss of weight to consider the pill as working. What do you think?

Read the full report here and here .

See full article .



Related Entries:

obesity and (related metabolic disorders) receptor, targeted by experimental drug - 08 March 2006
Miracle Weight Loss Pill - 05 May 2007
New Over-the-Counter Diet Pill - 18 June 2007
What are the dangers of diet pills? - 08 June 2007






Contents of this feed are a property of Creative Weblogging Limited and are protected by copyright laws. Violations will be prosecuted. Please email us if you'd like to use this feed for non-commercial activities at feeds - at - creative-weblogging.com.

The contents of this article belong to the individual publisher.